The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Sanofi via Globenewswire
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
89.45 EUR | -0.46% | -0.50% | -0.23% |
05-27 | Sanofi Gets US FDA’s Priority Review for Expanded Use of Blood Cancer Drug Sarclisa | MT |
05-27 | Sanofi: FDA grants priority review in myeloma | CF |
1st Jan change | Capi. | |
---|---|---|
-0.23% | 122B | |
+38.51% | 727B | |
+31.57% | 594B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+14.60% | 243B | |
+8.12% | 205B | |
-5.85% | 203B | |
+6.19% | 164B |